Deepika vegiraju at 12:44, 29 July 2023

2023-07-29T12:44:30Z

New page

* Drug development is a complex and rigorous process that transforms a promising molecule or compound into a safe and effective medication for treating various medical conditions.
* This multidisciplinary process involves a series of stages, extensive research, and regulatory approvals to ensure patient safety and therapeutic efficacy.

[[File:Drug discovery cycle.svg|thumb|Drug discovery cycle]]

<youtube>
title='''{{PAGENAME}}'''
movie_url=http://www.youtube.com/v/v=kQ18rDhhyko
embed_source_url=http://www.youtube.com/v/v=kQ18rDhhyko
&rel=1
wrap = yes
width=750
height=600
</youtube>

=='''Stages of Drug Development''' ==

===Discovery and Target Identification===
* The drug development process begins with the discovery of potential drug targets.
* Researchers identify specific molecules, proteins, or pathways that play a crucial role in the disease process.
* Target validation confirms that the selected target is relevant and modifiable for therapeutic intervention.

===Lead Discovery===
* Lead discovery involves identifying potential drug candidates that can interact with the selected target.
* High-throughput screening, virtual screening, and other experimental and computational techniques are used to screen large libraries of compounds to find leads that show promise in interacting with the target.

===Lead Optimization===
* Once lead compounds are identified, they undergo extensive chemical modification and optimization to improve their [[potency]], [[selectivity]], [[pharmacokinetics]], and safety profile.
* Medicinal chemists work on synthesizing and testing a series of analogs to identify the most promising candidate for further development.

===Preclinical Development===
* Preclinical development involves testing the selected lead candidate in laboratory and animal studies to assess its safety, efficacy, pharmacokinetics, and toxicology.
* The goal is to gather sufficient data to support the initiation of clinical trials in humans.

=='''Clinical Development'''==

* Clinical development consists of three phases of human trials:

* a. '''Phase I:''' The drug is tested on a small group of healthy volunteers to evaluate its safety, tolerability, and [[pharmacokinetics]].
* b. '''Phase II:''' The drug is tested on a larger group of patients with the target disease to assess its effectiveness, optimal dosing, and further safety evaluation.
* c. '''Phase III:''' The drug is tested on a large number of patients to confirm its safety and efficacy in real-world conditions. The data generated in this phase are crucial for regulatory approval.

=='''Regulatory Review'''==
* After the successful completion of Phase III trials, the drug developer submits a [[New Drug Application]] (NDA) or [[Biologics License Application]] (BLA) to the relevant regulatory agency, such as the U.S. [[Food and Drug Administration]] (FDA) in the United States.
* Regulatory authorities review the data to determine whether the drug's benefits outweigh its risks, leading to approval or rejection.

=='''Post-Marketing Surveillance'''==
* Once a drug is approved and enters the market, post-marketing surveillance is conducted to monitor its safety and effectiveness in a larger patient population.
* Adverse reactions or interactions not detected during clinical trials may emerge during this phase.

=='''Importance of Collaboration''' ==
* Drug development is a collaborative effort that involves coordination among various stakeholders, including pharmaceutical companies, academic researchers, regulatory agencies, healthcare providers, and patients.
* Collaboration allows for the integration of expertise from different disciplines, such as chemistry, biology, pharmacology, clinical research, and regulatory affairs, to ensure the success of the drug development process.

=='''Conclusion'''==
* Drug development is a rigorous and time-consuming process that involves multiple stages, from target identification to regulatory approval and post-marketing surveillance.
* It requires close collaboration among researchers, pharmaceutical companies, regulatory agencies, and healthcare professionals to bring safe and effective medications to patients in need.
* The continuous advancement of science and technology in drug development holds promise for the discovery of novel therapies and the improvement of global healthcare.

== '''References''' ==

* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5076188/ Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov. 2011;10(6):428-438. doi:10.1038/nrd3405.]
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713034/ Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov. 2004;3(8):711-715. doi:10.1038/nrd1470.]
* [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087959/ Berke Z, Palmer M. Drug discovery: an operating model for a new era. Drug Discov Today. 2018;23(8):1507-1512. doi:10.1016/j.drudis.2018.05.017.]

== '''See also''' ==
* [[Drug design]]
* [[Drug repositioning]]
* [[Pharmaceutical engineering]]
* [[Pharmaceutical manufacturing]]
* [[Generic drug]]

{{stb}}

{{drug design}}
{{Pharmacy}}

[[Category:Pharmacology]]
[[Category:Medicinal Chemistry]]
[[Category:Clinical Trials]]
[[Category:Regulatory Affairs]]
[[Category:Pharmaceutical Industry]]
[[Category:Medical Research]]

[[Category:Pharmaceutical industry]]
[[Category:Drug discovery]]
[[Category:Life sciences industry]]

Drug development - Revision history

Deepika vegiraju at 12:44, 29 July 2023